Macrocyclic factor VIIA inhibitors useful as anticoagulants

Details for Australian Patent Application No. 2007337025 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Wurtz, Nicholas Ronald; Cheney, Daniel L.; Mueller, Luciano; Glunz, Peter W.; Ladziata, Vladimir; Parkhurst, Brandon; Priestley, Eldon Scott; Zhang, Xiaojun

Agent A J Park

Pub. Number AU-A-2007337025

PCT Pub. Number WO2008/079836

Priority 60/870,864 20.12.06 US; 60/984,460 01.11.07 US

Filing date 19 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 255/04 (2006.01) Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups

C07D 271/12 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079836 Priority application(s): WO2008/079836

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337054-Connection system

2007337024-Splittable wire guide